Inventor
Edward PAINTER
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,275,739Inhibitors of menin-MLL interaction202512,116,371Substituted pyridines as irreversible inhibitors of menin-MLL interaction202412,077,544Irreversible inhibitors of menin-MLL interaction202411,845,753Inhibitors of menin-mll interaction202311,702,421Substituted pyridines as irreversible inhibitors of menin-MLL interaction202311,174,263Inhibitors of menin-MLL interaction2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to BIOMEA FUSION INC (5)· patent assignee history
2021–2023Patents assigned to BIOMEA FUSION LLC (2)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOMEA FUSION INC | 5 | 2021–2025 |
| BIOMEA FUSION LLC | 2 | 2021–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2025 |